Peptide safety claims in bodybuilding TikToks: what holds up?

What did @jedweaver_ actually say?

The creator walked 4.9 million viewers through MK-677, calling it "the most dangerous natty plus supplement" because it can push users into "a pre-diabetic state." They explained that MK-677 mimics ghrelin, raises growth hormone and IGF-1, and reduces insulin sensitivity. Their fix: berberine or metformin alongside regular blood glucose monitoring. They also plugged a purchase link in their bio and offered DM consultations on Instagram.

The core message is directionally correct. MK-677 does affect insulin sensitivity in documented ways. But the framing, the remedies, and the casual sales pitch at the end all deserve scrutiny before anyone acts on this advice.

Does the science back this up?

Yes, with significant caveats. MK-677 (ibutamoren) is a ghrelin receptor agonist, not a peptide, and its effect on insulin sensitivity is real and well-documented. A randomized controlled trial by Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) found that MK-677 increased fasting blood glucose and insulin levels in older adults. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed similar glycemic effects in younger subjects. So the creator is not making this up.

The mechanism is also roughly right. Growth hormone elevation suppresses insulin-mediated glucose uptake in muscle tissue, a well-established physiological relationship described in reviews by Moller and Jorgensen (2009, Endocrine Reviews). Elevated IGF-1 has some opposing, insulin-sensitizing effects, but they do not fully offset GH-driven insulin resistance at the doses people typically use recreationally.

What did they get wrong (or right)?

They got the insulin resistance mechanism right. Credit where it is due. But calling berberine and metformin "glucose disposal agents" and implying they are interchangeable or casually stackable is where things get messy.

Metformin is a prescription drug. Recommending it as a cycling companion without a physician's involvement is not harm reduction, it is liability dressed up as advice. Metformin also has its own interaction profile and contraindications. Berberine has modest supporting evidence: a meta-analysis by Dong et al. (2012, Evidence-Based Complementary and Alternative Medicine) found meaningful HbA1c reduction, but effect sizes were small and study quality was mixed. Treating it as a reliable insulin-sensitizer for a GH-driven glucose problem is an overreach.

The creator also frames MK-677 as a "natty plus" supplement, implying it sits in a category of relatively benign performance enhancers. It is not approved by the FDA for any indication in humans and is on the World Anti-Doping Agency's prohibited list. Calling it "a skinny guy's best friend" while acknowledging pre-diabetic risk in the same breath is a contradiction the video never resolves.

What should you actually know?

MK-677 is not a peptide and it is not a supplement in any regulated sense. It is an investigational compound that has never completed Phase III trials for any approved indication. Buying it from a link in a TikTok bio means you have no verified purity, no dosing standard, and no clinical oversight.

The creator is right that blood glucose monitoring matters. But monitoring alone does not make self-administration safe. If you develop insulin resistance or glucose intolerance, you need a clinician who can interpret your labs in context, not a DM from an Instagram account. A 2023 review by Svensson et al. in Growth Hormone and IGF Research noted that GH secretagogues consistently produce dose-dependent glycemic changes that require individualized clinical monitoring, not generic cycling protocols.

If you are genuinely interested in peptide or GH secretagogue therapy, a regulated telehealth platform with licensed prescribers and lab oversight is the appropriate starting point, not a TikTok comment section.

Does the sales pitch at the end change anything?

Yes, and not in a good way. The video correctly identifies a real metabolic risk, walks through the biology reasonably well, and then immediately directs viewers to buy the compound from the creator's affiliate link. That is a conflict of interest. The risk information exists, functionally, to make the pitch seem responsible. The FDA has issued repeated warnings about purchasing unapproved investigational compounds through unregulated channels. Whatever the creator's intentions, this structure, educate about risk, then sell the product, is a pattern worth recognizing before clicking any link.